Tobramycin and Tracheitis - a phase IV clinical study of FDA data

Summary:

Tracheitis is reported as a side effect among people who take Tobramycin (tobramycin), especially for people who are male, 2-9 old, also take Sodium Chloride, and have Lennox-gastaut syndrome.

The phase IV clinical study analyzes which people have Tracheitis when taking Tobramycin. It is created by eHealthMe based on reports of 3,545 people who have side effects when taking Tobramycin from the FDA, and is updated regularly.

What is Tobramycin?

Tobramycin has active ingredients of tobramycin. It is often used in cystic fibrosis. eHealthMe is studying from 3,579 Tobramycin users. Check the latest studies of Tobramycin.

What is Tracheitis?

Tracheitis (an inflammation of the trachea) is found to be associated with 199 drugs and 471 conditions by eHealthMe. Check the latest studies of Tracheitis.

On May, 12, 2026

3,545 people reported to have side effects when taking Tobramycin.
Among them, 15 people (0.42%) have Tracheitis.

Among these 15 people:

What is the gender of people who have Tracheitis when taking Tobramycin? *

female: 26.67 %
male: 73.33 %

What is the age of people who have Tracheitis when taking Tobramycin? *

What are other drugs people take besides Tobramycin? *

Sodium Chloride: 6 people, 40.00%
Epidiolex: 5 people, 33.33%
Miralax: 5 people, 33.33%
Acetaminophen: 4 people, 26.67%
Famotidine: 3 people, 20.00%
Melatonin: 3 people, 20.00%
Keppra Xr: 3 people, 20.00%
Furosemide: 3 people, 20.00%
Fluticasone Propionate: 3 people, 20.00%
Flovent Hfa: 3 people, 20.00%

What are other side effects people have besides Tracheitis? *

Pneumonia: 4 people, 26.67%
Weight Decreased: 3 people, 20.00%
Chronic Respiratory Disease: 3 people, 20.00%
Pneumonia Pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa): 3 people, 20.00%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 20.00%
Hypersensitivity: 3 people, 20.00%
Respiratory Syncytial Virus Infection (viral disease of respiratory system): 2 people, 13.33%
Infusion Site Mass: 2 people, 13.33%
Parainfluenzae Virus Infection: 2 people, 13.33%
Pneumonia Bacterial (pneumonia associated with bacterial infection): 2 people, 13.33%

What are the existing conditions these people have? *

Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 4 people, 26.67%
Infection: 2 people, 13.33%
Seasonal Allergy (allergic condition due to certain season): 2 people, 13.33%
Chronic Respiratory Failure: 2 people, 13.33%
Immunodeficiency Common Variable: 2 people, 13.33%
Growth Hormone Deficiency: 1 person, 6.67%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 6.67%
Chronic Respiratory Disease: 1 person, 6.67%
Constipation: 1 person, 6.67%
Dependence On Respirator: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Tobramycin and have Tracheitis?

- Check whether Tracheitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tobramycin:

Tobramycin (3,579 reports)

Tracheitis treatments and more:

Tracheitis (1,444 reports)

Browse all side effects of Tobramycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tracheitis:

Tracheitis (199 drugs)

Browse all the conditions that are associated with Tracheitis:

Tracheitis (471 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tobramycin (the active ingredients of Tobramycin) and Tobramycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.